State Board of Pharmacy and Employers, prohibited from disciplining pharmacists who recommend off-label medical treatments

HB 79 prohibits the State Board of Pharmacy and employers from disciplining pharmacists who recommend off-label medical treatments to patients. This directly affects pharmacists, protecting them from professional penalties when suggesting medications for uses not specifically approved by the FDA. The key provision bans disciplinary actions against pharmacists for providing such recommendations during patient consultations. The bill aims to expand pharmacists' role in patient care by allowing them to discuss off-label options without fear of licensing or employment repercussions.